FRANKLIN, TN (MMD Newswire) March 23, 2012 -- Gary Friedlaender purchased 15,000 shares of Biomimetic Therapeutics, Inc stock, or $32,852 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on March 19, 2012.
After the transaction, Gary Friedlaender's stake was reported as 33,995 shares of Biomimetic Therapeutics, Inc stock. Gary Friedlaender's title was listed as "Director" at Biomimetic Therapeutics, Inc within the filing.
As noted on March 21, 2012, Gary Friedlaender's purchase was done partially through "In Trust for Daughter" over 3 transactions on March 19, 2012. The share price ranged from $2.18 to $2.2 according to the regulatory filing detailing the transactions.
If we look over the past 12 months, Gary Friedlaender has sold no shares of Biomimetic Therapeutics, Inc stock. Over the same time period, Gary Friedlaender has purchased 15,000 shares of Biomimetic Therapeutics, Inc, with a total cost of $32,852. Gary Friedlaender has also performed other transactions including exercise of options .
Let's take a quick, high-level look at insider trading at Biomimetic Therapeutics, Inc over the past 12 months. A total of 36,500 shares of Biomimetic Therapeutics, Inc stock was sold by insiders, totaling $126,323. Over the same time 12 month time period, 29,900 shares of Biomimetic Therapeutics, Inc, for a total value of $150,206 were purchased by company insiders.
Source: SEC Filings